CTDHoldings 24st Centry Investments Cydodextrins
  • Home
  • Company Info
    • Overview
    • Management Team
    • Board of Directors
    • Mission & Vision
  • Cyclodextrins
    • Trappsol® Cyclo™
    • Trappsol®
    • Aquaplex®
    • Applications
  • Subsidiaries
    • CTD, Inc.
  • Our Business
    • Cyclodextrin Market
  • Media Center
    • Company News
    • Selected Articles
  • Investors
    • News / Events
      • Company News
      • In The News
      • Selected Articles
      • Presentations
      • Email Alerts
    • Company Information
      • Profile
      • Management Team
      • IR Contacts
      • FAQ
    • Financial Information
      • Financials
    • Stock Information
      • Quote
      • Charts
      • Historical Quotes
    • SEC Filings
      • All SEC Filings
      • Insiders
    • Corporate Governance
      • Board of Directors
      • Governance Documents
  • Contact Us
 

Company News

  • Home
  • Investors
  • News / Events
  • Company News
  • All News
  • By Year:
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • CTD Holdings Closes $2.0 Million Private Placement
    Dec 21, 2018, 8:00 AM EST
  • CTD Holdings to Present at WORLD Symposium on Lysosomal Storage Diseases
    Dec 12, 2018, 8:00 AM EST
  • CTD Holdings to Present at Brains for Brain Conference on Lysosomal Storage Diseases
    Dec 10, 2018, 9:11 AM EST
  • CTD Holdings Engages Torreya Capital as Strategic Advisor
    Nov 13, 2018, 8:43 AM EST
  • CTD Announces Partnership with Synteract to support the Extension Protocol for its Phase I Clinical Trial in the United States
    Nov 8, 2018, 3:07 PM EST
  • CTD Holdings Announces Filing of Patent Application for Use of Hydroxypropyl Beta Cyclodextrins in the Treatment of Alzheimer’s Disease
    Oct 29, 2018, 6:49 PM EDT
  • CTD Holdings Posts Recording of its Webinar on US Clinical Trial
    Oct 18, 2018, 4:31 PM EDT
  • CTD Holdings Announces Plans to Broaden its Expanded Access Program for Trappsol® Cyclo™
    Oct 15, 2018, 8:00 AM EDT
  • CTD Holdings to Host Webinar on its Phase I Clinical Trial for Niemann-Pick Disease Type C
    Oct 11, 2018, 12:57 PM EDT
  • CTD Holdings to Present at BioFlorida Conference with update on Clinical Program Using Cyclodextrins to treat diseases with Unmet Medical Needs
    Oct 9, 2018, 12:03 PM EDT
RSS
  • 1
  • 2
  • 3
  • Next >>
Show All
  • News / Events
    • Company News
    • In The News
    • Selected Articles
    • Presentations
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Information
  • SEC Filings
  • Corporate Governance

Links

  • Home
  • Cyclodex
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions
  • Sitemap
  • Contact Us

Investor Quicklinks

  • image description
    IR Overview
  • image description
    IR Contacts
  • image description
    IR FAQ
  • image description
    News/Events
  • image description
    Financial Info
  • image description
    SEC Filing
  • image description
    Corporate Governance
  • image description
    Stock Info

Connect With Us

  • rss
  • youtube
  • mail
© Copyright 2021 Cyclo Therapeutics, Inc. All Rights Reserved. Website by Equisolve